"You decide and we provide."
Cart 0

BRIEF-Auris Medical reports key results from Keyzilen Ampact2 open-label extension study




reutersCOMPANYNEWS companyNews

* Auris medical reports key results from Keyzilen Ampact2 open-label extension study




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published